Fujiwara, Saeko
Ishii, Shigeyuki
Hamasaki, Takahiko
Okimoto, Nobukazu
Article History
Received: 9 March 2021
Accepted: 14 June 2021
First Online: 30 June 2021
Declarations
:
: This study was approved by the Ethics Committee of Yasuda Women’s University.
: Not applicable.
: Not applicable.
: SF has received consultant fees from Teijin Pharma Inc. SI, and TH None. NO has received payments for lectures, including speakers’ bureau fees, from Asahi-Kasei Pharmaceutical Co., Ltd.; Amgen Astellas BioPharma K.K.; Astellas Pharma Inc.; Chugai Pharmaceutical Co.; Daiichi-Sankyo Co. Ltd.; Eisai Co., Ltd.; Eli Lilly Japan.; and Teijin Pharma Ltd.